person · Reporting owner
Elliott Jeffrey Thomas
Disclosed activity across 5 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EXACT SCIENCES CORPEXAS · Entity 56619 | Chief Financial Officer | April 30, 2024 | May 02, 2024 |
| EXAGEN INC.XGN · Entity 935 | Director | June 18, 2020 | July 02, 2020 |
| ICON PLCICLR · Entity 3439 | Director | August 10, 2026 | August 11, 2026 |
| Quanterix CorpQTRX · Entity 6649 | Director | August 19, 2026 | August 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EXACT SCIENCES CORP
Report date April 30, 2024 · Filed May 02, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,795 |
Last balance in matching sequence
After 2024-05-01 transaction · row 3
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
3 source rowsRow 1 · 2024-04-30 · Grant · Acquired 291 · Balance 11,224 F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Row 2 · 2024-04-30 · Grant · Acquired 707 · Balance 11,931 F3: Represents shares of common stock purchased through Employee Stock Purchase Plan. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Row 3 · 2024-05-01 · Sale · Disposed 136 · Balance 11,795 F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units. F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectHeld in 401(k) Plan | 1,585 |
Reported balance
Holding disclosure · report date 2024-04-30 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,585 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents additional shares of common stock received upon settlement of a performance share unit award on April 30, 2024.
F2: In addition to the shares of Common Stock reported on this Form 4, which total 13,380 shares, Mr. Elliott also holds, in the aggregate, an additional 134,437 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.
F3: Represents shares of common stock purchased through Employee Stock Purchase Plan.
F4: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain performance stock units.
EXAGEN INC.
Report date June 18, 2020 · Filed July 02, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.00 · Expires 2030-06-17 | Direct | 9,000 |
Reported balance
After 2020-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-06-18 · Grant · Acquired 9,000 · Balance 9,000 F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date.
ICON PLC
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 1,324 |
Reported balance
After 2026-08-10 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-10 · Grant · Acquired 1,324 · Balance 1,324 F1: Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting. F2: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted share unit represents a contingent right to receive one ordinary share of the Issuer upon vesting, with a nominal conversion price equal to the par value of the ordinary shares (EUR 0.06) per underlying share automatically deducted from the reporting person's pay in connection with vesting.
F2: These restricted share units were granted on August 10, 2026 and are scheduled to vest on May 22, 2027.
Quanterix Corp
Report date August 19, 2026 · Filed August 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,345 |
Reported balance
After 2026-08-19 transaction · row 1
1 source rowRow 1 · 2026-08-19 · Exercise / conversion · Acquired 3,955 · Balance 15,345 F1: Restricted stock units convert into common stock on a one-for-one basis. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,075 |
Reported balance
After 2026-08-19 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-08-19 · Exercise / conversion · Disposed 3,955 · Balance 4,075 F2: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert into common stock on a one-for-one basis.
F2: On August 19, 2024, the reporting person was granted 11,985 restricted stock units, vesting 33%, 33%, and 34% on the first, second, and third anniversaries of the grant date, respectively.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
SERA PROGNOSTICS, INC.
Report date June 04, 2026 · Filed June 04, 2026
Section 16 reporting ended · disclosed 2026-06-04. Current position is not established by this disclosure.
No balance rows disclosed in this filing.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 31, 2020 Filed Aug 4, 2020 17:02 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 9,151 | $93.30 | $853,788.30 |
DisclosureSEC source: 0001209191-20-044729 · doc4.xml · nonDerivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,677 F2 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.82 to $93.80, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 17:02 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 5,633 | $92.39 | $520,432.87 |
DisclosureSEC source: 0001209191-20-044729 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,828 F2 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.78 to $92.77, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 17:02 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,400 | $91.18 | $127,652.00 |
DisclosureSEC source: 0001209191-20-044729 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,461 F2 · shares: The sale reported in this field was effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.77 to $91.65, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 17:02 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 6,638 | $21.68 | $143,911.84 |
DisclosureSEC source: 0001209191-20-044729 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 8,746 | $95.58 | $835,942.68 |
DisclosureSEC source: 0001209191-20-044120 · doc4.xml · nonDerivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,223 F3 · shares: In addition to the shares of Common Stock reported on this Form 4, which total 70,370 shares, Mr. Elliott also holds, in the aggregate, an additional 151,485 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 70,370 shares, Mr. Elliott also holds, in the aggregate, an additional 151,485 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-044120 · doc4.xml · derivative · entry 6 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 28, 2020. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 28, 2020. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 18,750 | $94.81 | $1,777,687.50 |
DisclosureSEC source: 0001209191-20-044120 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,969 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award, which were released on July 28, 2020. Read SEC document |
| June 18, 2020 Filed Jul 2, 2020 12:47 UTC | EXAGEN INC. XGN · Entity 935 | GrantStock Option(right to buy) · Derivative | 9,000 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001274737-20-000065 · wf-form4_159369394398024.xml · derivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2030-06-17 F1 · derivative.exercise_date: The entire number of shares subject to this option becomes fully vested and exercisable on the first to occur of (a) the first anniversary of the grant date or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the board of directors of the Issuer through such vesting date. Read SEC document |
| April 30, 2020 Filed Jul 30, 2020 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 351 | $60.60 | $21,270.60 |
DisclosureSEC source: 0001209191-20-044120 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,219 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 19:15 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,383 | $80.17 | $191,045.11 |
DisclosureSEC source: 0001209191-20-014808 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,578 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2020. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 59,905 shares, Mr. Elliott also holds, in the aggregate, an additional 170,235 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 27, 2020 Filed Feb 28, 2020 16:37 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 1,627 | $80.27 | $130,599.29 |
DisclosureSEC source: 0001209191-20-013912 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,116 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 26, 2020. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 57,263 shares, Mr. Elliott also holds, in the aggregate, an additional 175,260 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 19:15 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014808 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,050 Underlying: Common Stock · 5,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2020. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2020. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2020 Filed Mar 2, 2020 19:15 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 5,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-014808 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,141 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:37 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 3,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013912 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,311 Underlying: Common Stock · 3,436 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2020. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 26, 2019 that partially vested on February 26, 2020. The restricted stock units vest in four equal annual installments beginning on February 26, 2020. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 16:37 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 3,436 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013912 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 25, 2020 Filed Feb 26, 2020 17:13 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 4,910 | $85.11 | $417,890.10 |
DisclosureSEC source: 0001209191-20-013113 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,307 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units, which were released on February 24, 2020. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 55,454 shares, Mr. Elliott also holds, in the aggregate, an additional 178,696 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 17:13 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013113 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2020 and settled into shares of Common Stock on February 24, 2020. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2020 and settled into shares of Common Stock on February 24, 2020. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document |
| February 24, 2020 Filed Feb 26, 2020 17:13 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-013113 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,217 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 16:37 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantStock Option (right to buy) · Derivative | 12,875 | $0.00 Strike: $98.18 | $0.00 |
DisclosureSEC source: 0001209191-20-010170 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,875 Underlying: Common Stock · 12,875 shares Expires 2030-02-14 F4 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 16:37 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 15,888 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-010170 · doc4.xml · derivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,888 Underlying: Common Stock · 15,888 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| October 30, 2019 Filed Jul 30, 2020 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 110 | $60.60 | $6,666.00 |
DisclosureSEC source: 0001209191-20-044120 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,109 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| September 18, 2019 Filed Sep 20, 2019 22:56 UTC | EXAGEN INC. XGN · Entity 935 | GrantStock Option (right to buy) · Derivative | 13,613 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0000899243-19-024013 · doc4.xml · derivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,613 Underlying: Common Stock · 13,613 shares Expires 2029-09-17 F1 · derivative.exercise_date: The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on October 18, 2019, subject to the Reporting Person's continued service to the Issuer through each such vesting date. Read SEC document |
| July 30, 2019 Filed Jul 31, 2019 17:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 9,845 | $105.60 | $1,039,632.00 |
DisclosureSEC source: 0001209191-19-043897 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,917 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units, which were released on July 29, 2019. F4 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 50,877 shares, Mr. Elliott also holds, in the aggregate, an additional 159,233 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-043897 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 29, 2019. The restricted stock units vest in four equal annual installments beginning on July 28, 2017. F6 · derivative.expiration_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 29, 2019. The restricted stock units vest in four equal annual installments beginning on July 28, 2017. Read SEC document |
| July 29, 2019 Filed Jul 31, 2019 17:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-043897 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award, which were released on July 29, 2019. Read SEC document |
| April 30, 2019 Filed Jul 31, 2019 17:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 368 | $60.60 | $22,300.80 |
DisclosureSEC source: 0001209191-19-043897 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,012 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| February 28, 2019 Filed Mar 1, 2019 17:29 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,447 | $93.20 | $228,070.19 |
DisclosureSEC source: 0001209191-19-015119 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,644 F1 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 27, 2019. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 41,604 shares, Mr. Elliott also holds, in the aggregate, an additional 177,983 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 5,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014808 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,075 Underlying: Common Stock · 5,025 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F6 · derivative.exercise_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2019. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. F6 · derivative.expiration_date: Represents a restricted stock unit award granted on February 27, 2018 that partially vested on February 27, 2019. The restricted stock units vest in four equal annual installments beginning on February 27, 2019. Read SEC document |
| February 27, 2019 Filed Feb 28, 2019 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 5,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014808 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,091 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on February 27, 2019. F2 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 44,051 shares, Mr. Elliott also holds, in the aggregate, an additional 177,983 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 13,747 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-014808 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,747 Underlying: Common Stock · 13,747 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F5 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 26, 2019 Filed Feb 28, 2019 20:18 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantStock Option (right to buy) · Derivative | 11,361 | $0.00 Strike: $92.62 | $0.00 |
DisclosureSEC source: 0001209191-19-014808 · doc4.xml · derivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,361 Underlying: Common Stock · 11,361 shares Expires 2029-02-26 F3 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 25, 2019 Filed Feb 26, 2019 17:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 4,445 | $90.55 | $402,499.20 |
DisclosureSEC source: 0001209191-19-013659 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,066 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 23, 2019. F3 · balance_after: In addition to the shares of Common Stock reported on this Form 4, which total 39,026 shares, Mr. Elliott also holds, in the aggregate, an additional 157,900 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 17:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013659 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,600 Underlying: Common Stock · 9,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2019. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2019. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document |
| February 23, 2019 Filed Feb 26, 2019 17:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-013659 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,511 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award on February 23, 2019. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 18:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 52,694 | $79.48 | $4,188,329.90 |
DisclosureSEC source: 0001209191-19-005426 · doc4.xml · nonDerivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,211 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.09 to $79.515, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 5 to this Form 4. F6 · balance_after: In addition to the shares of Common Stock reported on this Form 4, Mr. Elliott also holds, in the aggregate, an additional 167,200 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 18:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 18,968 | $78.54 | $1,489,803.62 |
DisclosureSEC source: 0001209191-19-005426 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,905 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.035 to $79.01, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 4 to this Form 4. Read SEC document |
| January 24, 2019 Filed Jan 25, 2019 18:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 19,247 | $77.64 | $1,494,414.07 |
DisclosureSEC source: 0001209191-19-005426 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,873 F2 · shares: The sales reported in this field were effected pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.03 to $78.02, inclusive. The reporting person undertakes to provide to Exact Sciences Corporation, any security holder of Exact Sciences Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 3 to this Form 4. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 18:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionPerformance Share Units · Derivative | 90,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005426 · doc4.xml · derivative · entry 6 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 90,909 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_price: Each Performance Share Unit represents a right to receive one share of common stock. F8 · derivative.exercise_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the three-year period ending December 31, 2018 (the "Performance Period") as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25, representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 60,606 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs vested on January 2, 2019 and settled into shares of Common Stock on January 23, 2019. F8 · derivative.expiration_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the three-year period ending December 31, 2018 (the "Performance Period") as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25, representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 60,606 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs vested on January 2, 2019 and settled into shares of Common Stock on January 23, 2019. Read SEC document |
| January 23, 2019 Filed Jan 25, 2019 18:48 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 90,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-005426 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon settlement of a performance share unit award (the "PSU Award") on January 23, 2019, which is described further in Footnote 7 to this Form 4. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantPerformance Share Units · Derivative | 90,909 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-002051 · doc4.xml · derivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,909 Underlying: Common Stock · 90,909 shares Expires not disclosed F2 · security: Represents a PSU award granted on July 28, 2016 (the "PSU Award") which covered a three-year performance measurement period ending on December 31, 2018 (the "Performance Period") and was described in the Company's proxy statement filed with the Securities and Exchange Commission on April 28, 2017. F3 · derivative.exercise_price: Each Performance Share Unit represents a right to receive one share of common stock. F4 · derivative.exercise_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the end of the Performance Period as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 60,606 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs are immediately vested and will settle into shares of Common Stock within 30 days from the date of issuance. F4 · derivative.expiration_date: The PSU Award was subject to certain performance-based vesting requirements tied to the growth in the Company's stock price through the end of the Performance Period as calculated by reference to the 20 trading day trailing average closing price of the Company's common stock (the "Stock Price") as of the last day of the Performance Period compared to such Stock Price as of the beginning of the Performance Period. The Stock Price as of the last day of the Performance Period was $67.25 representing a greater than 760% increase from the $8.85 Stock Price at the beginning of the Performance Period. At target, the PSU Award covered 60,606 PSUs. Because the Stock Price at the end of the Performance Period well exceeded the maximum target Stock Price, the reporting person earned the maximum number of PSUs to which he was entitled under the PSU Award. The PSUs are immediately vested and will settle into shares of Common Stock within 30 days from the date of issuance. Read SEC document |
| October 31, 2018 Filed Jan 4, 2019 16:57 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 755 | $13.26 | $10,011.30 |
DisclosureSEC source: 0001209191-19-002051 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,211 F1 · shares: Represents shares of common stock purchased through Employee Stock Purchase Plan. Read SEC document |
| July 30, 2018 Filed Jul 31, 2018 20:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 8,984 | $57.78 | $519,095.52 |
DisclosureSEC source: 0001209191-18-044638 · doc4.xml · nonDerivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,456 F3 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on July 28, 2018. Read SEC document |
| July 28, 2018 Filed Jul 31, 2018 20:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044638 · doc4.xml · derivative · entry 5 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Underlying: Common Stock · 18,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F5 · derivative.exercise_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 28, 2018. The restricted stock units vest in four equal annual installments beginning on July 28, 2017. F5 · derivative.expiration_date: Represents a restricted stock unit award granted on July 28, 2016 that partially vested on July 28, 2018. The restricted stock units vest in four equal annual installments beginning on July 28, 2017. Read SEC document |
| July 28, 2018 Filed Jul 31, 2018 20:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-044638 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
| April 30, 2018 Filed Jul 31, 2018 20:34 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantCommon Stock | 1,678 | $13.26 | $22,250.28 |
DisclosureSEC source: 0001209191-18-044638 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,690 F1 · shares: Represents shares purchased through Employee Stock Purchase Plan. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 19:56 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantRestricted Stock Units · Derivative | 20,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014729 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,100 Underlying: Common Stock · 20,100 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: These restricted stock units vest in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 27, 2018 Filed Feb 28, 2018 19:56 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | GrantStock Option (right to buy) · Derivative | 16,700 | $0.00 Strike: $44.37 | $0.00 |
DisclosureSEC source: 0001209191-18-014729 · doc4.xml · derivative · entry 3 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,700 Underlying: Common Stock · 16,700 shares Expires 2028-02-28 F1 · derivative.exercise_date: These options vest and become exercisable in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| February 26, 2018 Filed Feb 27, 2018 18:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | SaleCommon Stock | 2,982 | $42.34 | $126,251.92 |
DisclosureSEC source: 0001209191-18-014138 · doc4.xml · nonDerivative · entry 2 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,012 F2 · shares: Represents shares sold pursuant to a Sell-to-Cover Rule 10b5-1 Plan to pay withholding taxes due in connection with the vesting of certain restricted stock units on February 23, 2018. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionRestricted Stock Units · Derivative | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014138 · doc4.xml · derivative · entry 4 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,900 Underlying: Common Stock · 9,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F4 · derivative.exercise_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2018. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. F4 · derivative.expiration_date: Represents a restricted stock unit award granted on February 23, 2017 that partially vested on February 23, 2018. The restricted stock units vest in four equal annual installments beginning on February 23, 2018. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 18:22 UTC | EXACT SCIENCES CORP EXAS · Entity 56619 | Exercise / conversionCommon Stock | 9,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-014138 · doc4.xml · nonDerivative · entry 1 Elliott Jeffrey Thomas · CIK 0001689757 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,994 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares of common stock received upon vesting of a restricted stock unit award. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.